Dr Kyle Mulrooney and Dr Katinka van de Ven | Special Issue in Q1 journal (IJDP)
In 2019, Dr. Kyle Mulrooney and Dr. Katinka van de Ven received network funding from HASSE to continuing growing the Human Enhancement Drugs Network. The funding was used to organise a symposium on Human Enhancement Drugs held at the UNE Campus in Paramatta. The...
Recent Comments